An observational study in Motor Development in Children, Developmental Coordination Disorder and Cerebral Palsy, sponsored by Chang Gung Memorial Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Chang Gung Memorial Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study aims to develop and validate the AI-Integrated Motor Assessment System (AIMAS) for evaluating motor skills in children aged 6 to 12 years. The study will include typically developing children and children with developmental delay or motor-related developmental disorders.
Participants will complete standardized gross and fine motor tasks while their movements are video-recorded for AI-based analysis. Some participants will also complete a standardized clinical motor assessment for comparison.
The study will evaluate the reliability, validity, and accuracy of AIMAS, including its ability to identify children with motor difficulties. The long-term goal is to establish AIMAS as an accessible and efficient screening tool that can support earlier referral for further professional assessment.
This three-year study will develop and validate the AI-Integrated Motor Assessment System (AIMAS), an AI-based platform that uses video-recorded motor tasks and pose-estimation analysis to assess children's motor performance.
In Year 1, the study will expand the motion dataset, train the AI model, and evaluate reliability and validity. In Year 2, the model will be tested in a new population using measures including ROC curves, AUC, sensitivity, and specificity, and a motor developmental delay risk score will be developed. In Year 3, AIMAS will be evaluated in clinical and educational settings for feasibility, accuracy, and agreement with professional motor assessments.
Approximately 470 children aged 6 to 12 years will be enrolled, including typically developing children and children with developmental delay or motor-related developmental disorders. Participants will complete a one-time assessment involving gross and fine motor tasks, with video recordings collected for AI analysis. A subset will also complete a standardized motor assessment, such as the Bruininks-Oseretsky Test of Motor Proficiency, for criterion-related validation.
The overall goal is to establish AIMAS as a reliable, valid, and scalable screening tool for early identification of motor difficulties in children.
105 studies on the registry are indexed under Motor Skills Disorders; 29 are open to participants now.
This study's planned enrollment of 470 is above the median of 92 across 28 observational studies indexed under Motor Skills Disorders.
Browse Motor Skills Disorders studies →Chang Gung Memorial Hospital is the lead sponsor of 1,098 studies on the registry; 241 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population will include children aged 6 to 12 years recruited from collaborating hospital outpatient clinics and elementary schools. Participants will include typically developing children and children with developmental delay or motor-related developmental disorders, such as developmental coordination disorder, developmental delay, intellectual disability, mild cerebral palsy, autism spectrum disorder, or other clinician-confirmed developmental motor disorders.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Developmental Delay With Motor Disorder Group:
Typically Developing Group:
Exclusion Criteria:
Developmental Delay With Motor Disorder Group:
Typically Developing Group:
Children aged 6 to 12 years with typical development will complete standardized gross and fine motor assessments with video recording for AI-based analysis using the AI-Integrated Motor Assessment System (AIMAS).
Diagnostic Test: AI-Integrated Motor Assessment System (AIMAS)
Children aged 6 to 12 years with developmental delay or motor-related developmental disorders will complete standardized gross and fine motor assessments with video recording for AI-based analysis using AIMAS.
Diagnostic Test: AI-Integrated Motor Assessment System (AIMAS)
The AI-Integrated Motor Assessment System (AIMAS) is a video-based motor assessment system that uses artificial intelligence and pose-estimation analysis to evaluate gross and fine motor performance in children. Participants complete standardized motor tasks while their movements are video-recorded for AI-based analysis. A subset of participants also completes a standardized clinical motor assessment for validation of AIMAS results.
Diagnostic Accuracy of AIMAS for Identifying Motor Developmental Difficulties
Diagnostic accuracy of the AI-Integrated Motor Assessment System (AIMAS) in distinguishing typically developing children from children with developmental delay or motor-related developmental disorders. Classification performance will be quantified using the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity.
Time frame: Baseline (Day 1)
Reliability of AIMAS
Reliability of the AI-Integrated Motor Assessment System (AIMAS) will be quantified using intraclass correlation coefficients (ICC) for inter-rater and test-retest reliability. Inter-rater reliability will be determined by comparing AIMAS measurements obtained from independent raters, while test-retest reliability will be assessed using repeated motor assessments of the same participants. Consistency of AI-based joint and pose estimation will also be examined.
Time frame: Baseline (Day 1) and repeat assessment (Week 1)
Criterion Validity of AIMAS
Criterion-related validity of the AI-Integrated Motor Assessment System (AIMAS) will be examined by comparing AIMAS-derived motor performance scores with scores obtained from a standardized clinical motor assessment, such as the Bruininks-Oseretsky Test of Motor Proficiency (BOT), in a subset of participants. Associations between AIMAS scores and standardized assessment scores will be quantified using correlation coefficients.
Time frame: Baseline (Day 1)
Group Differences in AIMAS-Derived Motor Task Performance
Motor task performance will be compared between typically developing children and children with developmental delay or motor-related developmental disorders using quantitative measures derived from the AI-Integrated Motor Assessment System (AIMAS). Outcomes will include task completion time (seconds), task performance accuracy (percentage of correctly completed task components), and joint range of motion (degrees), as applicable to the standardized motor tasks. Between-group differences will be analyzed for each prespecified motor performance measure.
Time frame: Baseline (Day 1)
AIMAS-Derived Motor Developmental Delay Risk Score
A motor developmental delay risk score will be generated using AIMAS-derived movement features and classification model outputs. The score will represent the estimated probability of motor developmental difficulties, ranging from 0 to 1, with higher values indicating greater predicted risk.
Time frame: Baseline (Day 1)
Started Sep 2026 (actual). Primary completion is estimated for Sep 2029, 36 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chang Gung Memorial Hospital →